Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-01

FDA Approved: SODIUM PHENYLBUTYRATE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)

View source ↗

Summary

FDA approved Glenmark's generic sodium phenylbutyrate (Original Application) for use in treating patients with urea cycle disorders, expanding availability of a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium phenylbutyrate (sodium phenylbutyrate)

Snippet

ORIG AP for SODIUM PHENYLBUTYRATE (SODIUM PHENYLBUTYRATE)